Perioperative Management of Patients With Coronary Stents

Journal of the American College of Cardiology

Volumn 49, Issue 22, 2007, Pages 2145-2150

  Brilakis, Emmanouil S ^a   Banerjee, Subhash ^a   Berger, Peter B ^b  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b GEISINGER MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTITHROMBOCYTIC AGENT; CLOPIDOGREL; FIBRINOGEN RECEPTOR ANTAGONIST; HEPARIN;

BALLOON; CONTINUING EDUCATION; CORONARY STENT; DRUG ELUTING STENT; HEART INFARCTION; HEART MUSCLE REVASCULARIZATION; HUMAN; PERCUTANEOUS CORONARY INTERVENTION; PERIOPERATIVE PERIOD; POSTOPERATIVE THROMBOSIS; PRACTICE GUIDELINE; PREOPERATIVE CARE; PRIORITY JOURNAL; REVIEW; SURGICAL RISK; THROMBOSIS PREVENTION;

CORONARY THROMBOSIS; HUMANS; MYOCARDIAL REVASCULARIZATION; PERIOPERATIVE CARE; PLATELET AGGREGATION INHIBITORS; PRACTICE GUIDELINES; STENTS;

EID: 34249702973     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2007.02.046     Document Type: Review

References (42)

1. Eagle K.A., Berger P.B., Calkins H., et al. ACC/AHA guideline update for perioperative cardiovascular evaluation for noncardiac surgery-executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1996 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery). Circulation 105 (2002) 1257-1267
2. Al Suwaidi J., Berger P.B., and Holmes Jr. D.R. Coronary artery stents. JAMA 284 (2000) 1828-1836
3. Iakovou I., Schmidt T., Bonizzoni E., et al. Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents. JAMA 293 (2005) 2126-2130
4. Cheneau E., Leborgne L., Mintz G.S., et al. Predictors of subacute stent thrombosis: results of a systematic intravascular ultrasound study. Circulation 108 (2003) 43-47
5. Cutlip D.E., Baim D.S., Ho K.K., et al. Stent thrombosis in the modern era: a pooled analysis of multicenter coronary stent clinical trials. Circulation 103 (2001) 1967-1971
6. Fujii K., Carlier S.G., Mintz G.S., et al. Stent underexpansion and residual reference segment stenosis are related to stent thrombosis after sirolimus-eluting stent implantation: an intravascular ultrasound study. J Am Coll Cardiol 45 (2005) 995-998
7. Hausleiter J., Kastrati A., Mehilli J., et al. Predictive factors for early cardiac events and angiographic restenosis after coronary stent placement in small coronary arteries. J Am Coll Cardiol 40 (2002) 882-889
8. Mehilli J., Dibra A., Kastrati A., Pache J., Dirschinger J., and Schomig A. Randomized trial of paclitaxel- and sirolimus-eluting stents in small coronary vessels. Eur Heart J 27 (2006) 260-266
9. Ardissino D., Cavallini C., Bramucci E., et al. Sirolimus-eluting vs. uncoated stents for prevention of restenosis in small coronary arteries: a randomized trial. JAMA 292 (2004) 2727-2734
10. Ong A.T., McFadden E.P., Regar E., deJaegere P.P., vanDomburg R.T., and Serruys P.W. Late angiographic stent thrombosis (LAST) events with drug-eluting stents. J Am Coll Cardiol 45 (2005) 2088-2092
11. Leon M.B., Baim D.S., Popma J.J., et al., Stent Anticoagulation Restenosis Study Investigators. A clinical trial comparing three antithrombotic-drug regimens after coronary-artery stenting. N Engl J Med 339 (1998) 1665-1671
12. Sautter R.D., Myers W.O., Ray III J.F., and Wenzel F.J. Relationship of fibrinolytic system to postoperative thrombotic phenomena. Arch Surg 107 (1973) 292-296
13. Rosenfeld B.A., Beattie C., Christopherson R., et al., Perioperative Ischemia Randomized Anesthesia Trial Study Group. The effects of different anesthetic regimens on fibrinolysis and the development of postoperative arterial thrombosis. Anesthesiology 79 (1993) 435-443
14. Kaluza G.L., Joseph J., Lee J.R., Raizner M.E., and Raizner A.E. Catastrophic outcomes of noncardiac surgery soon after coronary stenting. J Am Coll Cardiol 35 (2000) 1288-1294
15. Wilson S.H., Fasseas P., Orford J.L., et al. Clinical outcome of patients undergoing noncardiac surgery in the two months following coronary stenting. J Am Coll Cardiol 42 (2003) 234-240
16. Sharma A.K., Ajani A.E., Hamwi S.M., et al. Major noncardiac surgery following coronary stenting: when is it safe to operate?. Catheter Cardiovasc Interv 63 (2004) 141-145
17. Reddy P.R., and Vaitkus P.T. Risks of noncardiac surgery after coronary stenting. Am J Cardiol 95 (2005) 755-757
18. Vicenzi M.N., Meislitzer T., Heitzinger B., Halaj M., Fleisher L.A., and Metzler H. Coronary artery stenting and noncardiac surgery-a prospective outcome study. Br J Anaesth 96 (2006) 686-693
19. McFadden E.P., Stabile E., Regar E., et al. Late thrombosis in drug-eluting coronary stents after discontinuation of antiplatelet therapy. Lancet 364 (2004) 1519-1521
20. Nasser M., Kapeliovich M., and Markiewicz W. Late thrombosis of sirolimus-eluting stents following noncardiac surgery. Catheter Cardiovasc Interv 65 (2005) 516-519
21. Compton P.A., Zankar A.A., Adesanya A.O., Banerjee S., and Brilakis E.S. Risk of noncardiac surgery after coronary drug-eluting stent implantation. Am J Cardiol 98 (2006) 1212-1213
22. Schouten O., vanDomburg R.T., Bax J.J., et al. Noncardiac surgery after coronary stenting: early surgery and interruption of antiplatelet therapy are associated with an increase in major adverse cardiac events. J Am Coll Cardiol 49 (2007) 122-124
23. Bakhru M., Saber W., Brotman D., et al. Is discontinuation of antiplatelet therapy after 6 months safe in patients with drug-eluting stents undergoing noncardiac surgery?. Cleve Clin J Med 73 (2006) S23
24. Fleron M.H., Dupuis M., Mottet P., LeFeuvre C., and Godet G. Non cardiac surgery in patient with coronary stenting: think sirolimus now!. Ann Fr Anesth Reanim 22 (2003) 733-735
25. McFalls E.O., Ward H.B., Moritz T.E., et al. Coronary-artery revascularization before elective major vascular surgery. N Engl J Med 351 (2004) 2795-2804
26. Poldermans D., Schouten O., Vidakovic R., et al., DECREASE Study Group. A clinical randomized trial to evaluate the safety of a noninvasive approach in high-risk patients undergoing major vascular surgery: the DECREASE-V pilot study. J Am Coll Cardiol 49 (2007) 1763-1769
27. Huber K.C., Evans M.A., Bresnahan J.F., Gibbons R.J., and Holmes Jr. D.R. Outcome of noncardiac operations in patients with severe coronary artery disease successfully treated preoperatively with coronary angioplasty. Mayo Clin Proc 67 (1992) 15-21
28. Gottlieb A., Banoub M., Sprung J., Levy P.J., Beven M., and Mascha E.J. Perioperative cardiovascular morbidity in patients with coronary artery disease undergoing vascular surgery after percutaneous transluminal coronary angioplasty. J Cardiothorac Vasc Anesth 12 (1998) 501-506
29. Brilakis E.S., Orford J.L., Fasseas P., et al. Outcome of patients undergoing balloon angioplasty in the two months prior to noncardiac surgery. Am J Cardiol 96 (2005) 512-514
30. Morice M.C., Serruys P.W., Sousa J.E., et al. A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med 346 (2002) 1773-1780
31. Stone G.W., Ellis S.G., Cox D.A., et al. A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease. N Engl J Med 350 (2004) 221-231
32. Finn A.V., Kolodgie F.D., Harnek J., et al. Differential response of delayed healing and persistent inflammation at sites of overlapping sirolimus- or paclitaxel-eluting stents. Circulation 112 (2005) 270-278
33. Chu W.W., Kuchulakanti P.K., Torguson R., et al. Impact of overlapping drug-eluting stents in patients undergoing percutaneous coronary intervention. Catheter Cardiovasc Interv 67 (2006) 595-599
34. Eisenstein E.L., Anstrom K.J., Kong D.F., et al. Clopidogrel use and long-term clinical outcomes after drug-eluting stent implantation. JAMA 297 (2007) 159-168
35. Valerin M., Brennan M., Noll J., et al. Relationship between aspirin use and postoperative bleeding from dental extractions in a healthy population. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 102 (2006) 326
36. Kumar N., Jivan S., Thomas P., and McLure H. Sub-Tenon's anesthesia with aspirin, warfarin, and clopidogrel. J Cataract Refract Surg 32 (2006) 1022-1025
37. Alam M., and Goldberg L.H. Serious adverse vascular events associated with perioperative interruption of antiplatelet and anticoagulant therapy. Dermatol Surg 28 (2002) 992-998 discussion 998
38. Grines C.L., Bonow R.O., Casey Jr. D.E., et al. Prevention of premature discontinuation of dual antiplatelet therapy in patients with coronary artery stents: a science advisory from the American Heart Association, American College of Cardiology, Society for Cardiovascular Angiography and Interventions, American College of Surgeons, and American Dental Association, with representation from the American College of Physicians. J Am Coll Cardiol 49 (2007) 734-739
39. Orford J.L., Lennon R., Melby S., et al. Frequency and correlates of coronary stent thrombosis in the modern era: analysis of a single center registry. J Am Coll Cardiol 40 (2002) 1567-1572
40. Patterson L., Hunter D., and Mann A. Appropriate waiting time for noncardiac surgery following coronary stent insertion: views of Canadian anesthesiologists. Can J Anaesth 52 (2005) 440-441
41. Dupuis J.Y., and Labinaz M. Noncardiac surgery in patients with coronary artery stent: what should the anesthesiologist know?. Can J Anaesth 52 (2005) 356-361
42. Berger P.B., Bellot V., Bell M.R., et al. An immediate invasive strategy for the treatment of acute myocardial infarction early after noncardiac surgery. Am J Cardiol 87 (2001) 1100-1102